04-06-2026 08:10 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Quarterly Results
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 394.82
NSE Code AUROPHARMA
Dividend Yield % 0.28
Market Cap 828716.78
P/E 34.32
EPS 41.97
Face Value 1  
Quarters :
(Rs. in Million)
Particulars (Rs in Million) Mar 2026Dec 2025Sep 2025Jun 2025
 Audited / UnAudited UnAudited UnAudited UnAudited Audited
Net Sales 27865.50 27472.80 27897.20 28481.70
Total Expenditure 20051.30 19578.00 20650.20 20518.30
PBIDT (Excl OI) 7814.20 7894.80 7247.00 7963.40
Other Income 2140.90 1301.50 1595.20 837.70
Operating Profit 9955.10 9196.30 8842.20 8801.10
Interest 472.70 484.30 574.50 600.00
Exceptional Items 0 -173.80 0 0
PBDT 9482.40 8538.20 8267.70 8201.10
Depreciation 719.30 719.20 714.90 700.20
Profit Before Tax 8763.10 7819.00 7552.80 7500.90
Tax 1840.80 1998.30 1739.10 1909.60
Provisions and contingencies 0 0 0 0
Profit After Tax 6922.30 5820.70 5813.70 5591.30
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 6922.30 5820.70 5813.70 5591.30
Equity Capital 580.80 580.80 580.80 580.80
Face Value (IN RS) 1 1 1 1
Reserves    
Calculated EPS 11.92 10.02 10.01 9.63
Calculated EPS (Annualised) 47.67 40.09 40.04 38.51
No of Public Share Holdings 279852902.00 279852902.00 279852902.00 279852902.00
% of Public Share Holdings 48.18 48.18 48.18 48.18
     
PBIDTM% (Excl OI) 28.04 28.74 25.98 27.96
PBIDTM% 35.73 33.47 31.70 30.90
PBDTM% 34.03 31.08 29.64 28.79
PBTM% 31.45 28.46 27.07 26.34
PATM% 24.84 21.19 20.84 19.63
 Notes Notes Notes Notes
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.